Review



p3-supplemented nucleofection buffer  (Lonza)


Bioz Verified Symbol Lonza is a verified supplier
Bioz Manufacturer Symbol Lonza manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Lonza p3-supplemented nucleofection buffer
    P3 Supplemented Nucleofection Buffer, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/supplemented+p3+nucleofection+buffer/4d+nucleofector/pmc11530573-341-11-13
    Average 90 stars, based on 1 article reviews
    p3-supplemented nucleofection buffer - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    Purification:

    Article Title: NOT gated T cells that selectively target EGFR and other widely expressed tumor antigens
    Article Snippet: hours post-transduction primary T cells were transfected with CRISPR-Cas9:sgRNA complexes. .. Briefly, cells were collected and washes with PBS before resuspending in supplemented P3 nucleofection buffer (Lonza). .. A quantity of 20 pmol of Cas9 (Synthego) was combined with 130 pmol B2M-targeting sgRNA (IDT) an

    Article Title: Compositions and methods for treating mesothelin positive cancers
    Article Snippet: h post-transduction, primary T cells were transfected with CRISPR-Cas9:sgRNA complexes. .. Briefly, cells were collected and washed with PBS before resuspending in supplemented P3 nucleofection buffer (Lonza). .. 20 pmol of Cas9 (Synthego) was combined with 130 pmol B2M-targeting sgRNA (Synthego) and i

    Article Title: Mesothelin-specific CAR-T cell therapy that incorporates an HLA-gated safety mechanism selectively kills tumor cells
    Article Snippet: hours post-transduction, primary T cells were transfected with CRISPR-Cas9:sgRNA complexes. .. Briefly, cells were collected and washed with PBS before resuspending in supplemented P3 nucleofection buffer (Lonza). .. A quantity of 20 pmol of Cas9 (Synthego) was combined with 130 pmol B2M-targeting sgRNA (Synth

    Virus:

    Article Title: NOT gated T cells that selectively target EGFR and other widely expressed tumor antigens
    Article Snippet: hours post-transduction primary T cells were transfected with CRISPR-Cas9:sgRNA complexes. .. Briefly, cells were collected and washes with PBS before resuspending in supplemented P3 nucleofection buffer (Lonza). .. A quantity of 20 pmol of Cas9 (Synthego) was combined with 130 pmol B2M-targeting sgRNA (IDT) an

    Article Title: Compositions and methods for treating mesothelin positive cancers
    Article Snippet: h post-transduction, primary T cells were transfected with CRISPR-Cas9:sgRNA complexes. .. Briefly, cells were collected and washed with PBS before resuspending in supplemented P3 nucleofection buffer (Lonza). .. 20 pmol of Cas9 (Synthego) was combined with 130 pmol B2M-targeting sgRNA (Synthego) and i

    Article Title: Mesothelin-specific CAR-T cell therapy that incorporates an HLA-gated safety mechanism selectively kills tumor cells
    Article Snippet: hours post-transduction, primary T cells were transfected with CRISPR-Cas9:sgRNA complexes. .. Briefly, cells were collected and washed with PBS before resuspending in supplemented P3 nucleofection buffer (Lonza). .. A quantity of 20 pmol of Cas9 (Synthego) was combined with 130 pmol B2M-targeting sgRNA (Synth

    Recombinant:

    Article Title: NOT gated T cells that selectively target EGFR and other widely expressed tumor antigens
    Article Snippet: hours post-transduction primary T cells were transfected with CRISPR-Cas9:sgRNA complexes. .. Briefly, cells were collected and washes with PBS before resuspending in supplemented P3 nucleofection buffer (Lonza). .. A quantity of 20 pmol of Cas9 (Synthego) was combined with 130 pmol B2M-targeting sgRNA (IDT) an

    Article Title: Compositions and methods for treating mesothelin positive cancers
    Article Snippet: h post-transduction, primary T cells were transfected with CRISPR-Cas9:sgRNA complexes. .. Briefly, cells were collected and washed with PBS before resuspending in supplemented P3 nucleofection buffer (Lonza). .. 20 pmol of Cas9 (Synthego) was combined with 130 pmol B2M-targeting sgRNA (Synthego) and i

    Article Title: Mesothelin-specific CAR-T cell therapy that incorporates an HLA-gated safety mechanism selectively kills tumor cells
    Article Snippet: hours post-transduction, primary T cells were transfected with CRISPR-Cas9:sgRNA complexes. .. Briefly, cells were collected and washed with PBS before resuspending in supplemented P3 nucleofection buffer (Lonza). .. A quantity of 20 pmol of Cas9 (Synthego) was combined with 130 pmol B2M-targeting sgRNA (Synth

    Cell Isolation:

    Article Title: NOT gated T cells that selectively target EGFR and other widely expressed tumor antigens
    Article Snippet: hours post-transduction primary T cells were transfected with CRISPR-Cas9:sgRNA complexes. .. Briefly, cells were collected and washes with PBS before resuspending in supplemented P3 nucleofection buffer (Lonza). .. A quantity of 20 pmol of Cas9 (Synthego) was combined with 130 pmol B2M-targeting sgRNA (IDT) an

    Article Title: Compositions and methods for treating mesothelin positive cancers
    Article Snippet: h post-transduction, primary T cells were transfected with CRISPR-Cas9:sgRNA complexes. .. Briefly, cells were collected and washed with PBS before resuspending in supplemented P3 nucleofection buffer (Lonza). .. 20 pmol of Cas9 (Synthego) was combined with 130 pmol B2M-targeting sgRNA (Synthego) and i

    Article Title: Mesothelin-specific CAR-T cell therapy that incorporates an HLA-gated safety mechanism selectively kills tumor cells
    Article Snippet: hours post-transduction, primary T cells were transfected with CRISPR-Cas9:sgRNA complexes. .. Briefly, cells were collected and washed with PBS before resuspending in supplemented P3 nucleofection buffer (Lonza). .. A quantity of 20 pmol of Cas9 (Synthego) was combined with 130 pmol B2M-targeting sgRNA (Synth

    Staining:

    Article Title: NOT gated T cells that selectively target EGFR and other widely expressed tumor antigens
    Article Snippet: hours post-transduction primary T cells were transfected with CRISPR-Cas9:sgRNA complexes. .. Briefly, cells were collected and washes with PBS before resuspending in supplemented P3 nucleofection buffer (Lonza). .. A quantity of 20 pmol of Cas9 (Synthego) was combined with 130 pmol B2M-targeting sgRNA (IDT) an

    Article Title: Compositions and methods for treating mesothelin positive cancers
    Article Snippet: h post-transduction, primary T cells were transfected with CRISPR-Cas9:sgRNA complexes. .. Briefly, cells were collected and washed with PBS before resuspending in supplemented P3 nucleofection buffer (Lonza). .. 20 pmol of Cas9 (Synthego) was combined with 130 pmol B2M-targeting sgRNA (Synthego) and i

    Article Title: Mesothelin-specific CAR-T cell therapy that incorporates an HLA-gated safety mechanism selectively kills tumor cells
    Article Snippet: hours post-transduction, primary T cells were transfected with CRISPR-Cas9:sgRNA complexes. .. Briefly, cells were collected and washed with PBS before resuspending in supplemented P3 nucleofection buffer (Lonza). .. A quantity of 20 pmol of Cas9 (Synthego) was combined with 130 pmol B2M-targeting sgRNA (Synth

    Control:

    Article Title: NOT gated T cells that selectively target EGFR and other widely expressed tumor antigens
    Article Snippet: hours post-transduction primary T cells were transfected with CRISPR-Cas9:sgRNA complexes. .. Briefly, cells were collected and washes with PBS before resuspending in supplemented P3 nucleofection buffer (Lonza). .. A quantity of 20 pmol of Cas9 (Synthego) was combined with 130 pmol B2M-targeting sgRNA (IDT) an

    Article Title: Compositions and methods for treating mesothelin positive cancers
    Article Snippet: h post-transduction, primary T cells were transfected with CRISPR-Cas9:sgRNA complexes. .. Briefly, cells were collected and washed with PBS before resuspending in supplemented P3 nucleofection buffer (Lonza). .. 20 pmol of Cas9 (Synthego) was combined with 130 pmol B2M-targeting sgRNA (Synthego) and i

    Article Title: Mesothelin-specific CAR-T cell therapy that incorporates an HLA-gated safety mechanism selectively kills tumor cells
    Article Snippet: hours post-transduction, primary T cells were transfected with CRISPR-Cas9:sgRNA complexes. .. Briefly, cells were collected and washed with PBS before resuspending in supplemented P3 nucleofection buffer (Lonza). .. A quantity of 20 pmol of Cas9 (Synthego) was combined with 130 pmol B2M-targeting sgRNA (Synth

    TaqMan Assay:

    Article Title: NOT gated T cells that selectively target EGFR and other widely expressed tumor antigens
    Article Snippet: hours post-transduction primary T cells were transfected with CRISPR-Cas9:sgRNA complexes. .. Briefly, cells were collected and washes with PBS before resuspending in supplemented P3 nucleofection buffer (Lonza). .. A quantity of 20 pmol of Cas9 (Synthego) was combined with 130 pmol B2M-targeting sgRNA (IDT) an

    Article Title: Compositions and methods for treating mesothelin positive cancers
    Article Snippet: h post-transduction, primary T cells were transfected with CRISPR-Cas9:sgRNA complexes. .. Briefly, cells were collected and washed with PBS before resuspending in supplemented P3 nucleofection buffer (Lonza). .. 20 pmol of Cas9 (Synthego) was combined with 130 pmol B2M-targeting sgRNA (Synthego) and i

    Article Title: Mesothelin-specific CAR-T cell therapy that incorporates an HLA-gated safety mechanism selectively kills tumor cells
    Article Snippet: hours post-transduction, primary T cells were transfected with CRISPR-Cas9:sgRNA complexes. .. Briefly, cells were collected and washed with PBS before resuspending in supplemented P3 nucleofection buffer (Lonza). .. A quantity of 20 pmol of Cas9 (Synthego) was combined with 130 pmol B2M-targeting sgRNA (Synth

    Luciferase:

    Article Title: NOT gated T cells that selectively target EGFR and other widely expressed tumor antigens
    Article Snippet: hours post-transduction primary T cells were transfected with CRISPR-Cas9:sgRNA complexes. .. Briefly, cells were collected and washes with PBS before resuspending in supplemented P3 nucleofection buffer (Lonza). .. A quantity of 20 pmol of Cas9 (Synthego) was combined with 130 pmol B2M-targeting sgRNA (IDT) an

    Article Title: Compositions and methods for treating mesothelin positive cancers
    Article Snippet: h post-transduction, primary T cells were transfected with CRISPR-Cas9:sgRNA complexes. .. Briefly, cells were collected and washed with PBS before resuspending in supplemented P3 nucleofection buffer (Lonza). .. 20 pmol of Cas9 (Synthego) was combined with 130 pmol B2M-targeting sgRNA (Synthego) and i

    Article Title: Mesothelin-specific CAR-T cell therapy that incorporates an HLA-gated safety mechanism selectively kills tumor cells
    Article Snippet: hours post-transduction, primary T cells were transfected with CRISPR-Cas9:sgRNA complexes. .. Briefly, cells were collected and washed with PBS before resuspending in supplemented P3 nucleofection buffer (Lonza). .. A quantity of 20 pmol of Cas9 (Synthego) was combined with 130 pmol B2M-targeting sgRNA (Synth

    Sequencing:

    Article Title: NOT gated T cells that selectively target EGFR and other widely expressed tumor antigens
    Article Snippet: hours post-transduction primary T cells were transfected with CRISPR-Cas9:sgRNA complexes. .. Briefly, cells were collected and washes with PBS before resuspending in supplemented P3 nucleofection buffer (Lonza). .. A quantity of 20 pmol of Cas9 (Synthego) was combined with 130 pmol B2M-targeting sgRNA (IDT) an

    Article Title: Compositions and methods for treating mesothelin positive cancers
    Article Snippet: h post-transduction, primary T cells were transfected with CRISPR-Cas9:sgRNA complexes. .. Briefly, cells were collected and washed with PBS before resuspending in supplemented P3 nucleofection buffer (Lonza). .. 20 pmol of Cas9 (Synthego) was combined with 130 pmol B2M-targeting sgRNA (Synthego) and i

    Article Title: Mesothelin-specific CAR-T cell therapy that incorporates an HLA-gated safety mechanism selectively kills tumor cells
    Article Snippet: hours post-transduction, primary T cells were transfected with CRISPR-Cas9:sgRNA complexes. .. Briefly, cells were collected and washed with PBS before resuspending in supplemented P3 nucleofection buffer (Lonza). .. A quantity of 20 pmol of Cas9 (Synthego) was combined with 130 pmol B2M-targeting sgRNA (Synth

    Construct:

    Article Title: NOT gated T cells that selectively target EGFR and other widely expressed tumor antigens
    Article Snippet: hours post-transduction primary T cells were transfected with CRISPR-Cas9:sgRNA complexes. .. Briefly, cells were collected and washes with PBS before resuspending in supplemented P3 nucleofection buffer (Lonza). .. A quantity of 20 pmol of Cas9 (Synthego) was combined with 130 pmol B2M-targeting sgRNA (IDT) an

    Article Title: Compositions and methods for treating mesothelin positive cancers
    Article Snippet: h post-transduction, primary T cells were transfected with CRISPR-Cas9:sgRNA complexes. .. Briefly, cells were collected and washed with PBS before resuspending in supplemented P3 nucleofection buffer (Lonza). .. 20 pmol of Cas9 (Synthego) was combined with 130 pmol B2M-targeting sgRNA (Synthego) and i

    Article Title: Mesothelin-specific CAR-T cell therapy that incorporates an HLA-gated safety mechanism selectively kills tumor cells
    Article Snippet: hours post-transduction, primary T cells were transfected with CRISPR-Cas9:sgRNA complexes. .. Briefly, cells were collected and washed with PBS before resuspending in supplemented P3 nucleofection buffer (Lonza). .. A quantity of 20 pmol of Cas9 (Synthego) was combined with 130 pmol B2M-targeting sgRNA (Synth

    Software:

    Article Title: NOT gated T cells that selectively target EGFR and other widely expressed tumor antigens
    Article Snippet: hours post-transduction primary T cells were transfected with CRISPR-Cas9:sgRNA complexes. .. Briefly, cells were collected and washes with PBS before resuspending in supplemented P3 nucleofection buffer (Lonza). .. A quantity of 20 pmol of Cas9 (Synthego) was combined with 130 pmol B2M-targeting sgRNA (IDT) an

    Article Title: Compositions and methods for treating mesothelin positive cancers
    Article Snippet: h post-transduction, primary T cells were transfected with CRISPR-Cas9:sgRNA complexes. .. Briefly, cells were collected and washed with PBS before resuspending in supplemented P3 nucleofection buffer (Lonza). .. 20 pmol of Cas9 (Synthego) was combined with 130 pmol B2M-targeting sgRNA (Synthego) and i

    Article Title: Mesothelin-specific CAR-T cell therapy that incorporates an HLA-gated safety mechanism selectively kills tumor cells
    Article Snippet: hours post-transduction, primary T cells were transfected with CRISPR-Cas9:sgRNA complexes. .. Briefly, cells were collected and washed with PBS before resuspending in supplemented P3 nucleofection buffer (Lonza). .. A quantity of 20 pmol of Cas9 (Synthego) was combined with 130 pmol B2M-targeting sgRNA (Synth

    Incubation:

    Article Title: NOT gated T cells that selectively target EGFR and other widely expressed tumor antigens
    Article Snippet: hours post-transduction primary T cells were transfected with CRISPR-Cas9:sgRNA complexes. .. Briefly, cells were collected and washes with PBS before resuspending in supplemented P3 nucleofection buffer (Lonza). .. A quantity of 20 pmol of Cas9 (Synthego) was combined with 130 pmol B2M-targeting sgRNA (IDT) an

    Article Title: Compositions and methods for treating mesothelin positive cancers
    Article Snippet: h post-transduction, primary T cells were transfected with CRISPR-Cas9:sgRNA complexes. .. Briefly, cells were collected and washed with PBS before resuspending in supplemented P3 nucleofection buffer (Lonza). .. 20 pmol of Cas9 (Synthego) was combined with 130 pmol B2M-targeting sgRNA (Synthego) and i

    Article Title: Mesothelin-specific CAR-T cell therapy that incorporates an HLA-gated safety mechanism selectively kills tumor cells
    Article Snippet: hours post-transduction, primary T cells were transfected with CRISPR-Cas9:sgRNA complexes. .. Briefly, cells were collected and washed with PBS before resuspending in supplemented P3 nucleofection buffer (Lonza). .. A quantity of 20 pmol of Cas9 (Synthego) was combined with 130 pmol B2M-targeting sgRNA (Synth



    Similar Products

    90
    Lonza p3-supplemented nucleofection buffer
    P3 Supplemented Nucleofection Buffer, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/supplemented+p3+nucleofection+buffer/4d+nucleofector/pmc11530573-341-11-13
    Average 90 stars, based on 1 article reviews
    p3-supplemented nucleofection buffer - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Lonza supplemented p3 nucleofection buffer

    Supplemented P3 Nucleofection Buffer, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/supplemented+p3+nucleofection+buffer/4d+nucleofector/pmc11126980-521-12-15
    Average 90 stars, based on 1 article reviews
    supplemented p3 nucleofection buffer - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    Journal: iScience

    Article Title: NOT gated T cells that selectively target EGFR and other widely expressed tumor antigens

    doi: 10.1016/j.isci.2024.109913

    Figure Lengend Snippet:

    Article Snippet: Briefly, cells were collected and washes with PBS before resuspending in supplemented P3 nucleofection buffer (Lonza).

    Techniques: Purification, Virus, Recombinant, Cell Isolation, Staining, Control, TaqMan Assay, Luciferase, Sequencing, Construct, Software